EquityZen Growth Technology Fund LLC - Series 2329 (CIK: 0002134234) EDGAR, Information, Filings... CompaniesBIO.Com

EquityZen Growth Technology Fund LLC - Series 2329

Mailing address
1 NEW YORK PLAZA, 12TH FLOOR, NEW YORK, Delaware, 10004
Phone
8774906121
State location
New York
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

EquityZen Growth Technology Fund LLC - Series 2329 (CIK: 0002134234) is an American company incorporated in the state of New York. Head office is located at 1 NEW YORK PLAZA, 12TH FLOOR, NEW YORK, New York, 10004. Work in the industry N/A. EquityZen Growth Technology Fund LLC - Series 2329 is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by EquityZen Growth Technology Fund LLC - Series 2329

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002134234-26-000001 (33 Act) Size: KB	Jun-29-2026	021-588921 261133454

Recent 20 filings. View all EquityZen Growth Technology Fund LLC - Series 2329 filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

EquityZen Growth Technology Fund LLC - Series 2329 overview
EquityZen Growth Technology Fund LLC - Series 2329 job
EquityZen Growth Technology Fund LLC - Series 2329 stock
EquityZen Growth Technology Fund LLC - Series 2329 ownership
EquityZen Growth Technology Fund LLC - Series 2329 CEO
EquityZen Growth Technology Fund LLC - Series 2329 documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.